DENVER, Feb. 20 /PRNewswire-FirstCall/ - Accelr8 Technology Corporation and SCHOTT Nexterion(R) (SCHOTT JENAer GLAS GmbH, Jena, Germany) announced execution of a second OptiChem(R) license agreement to SCHOTT. The new license covers a second version of Accelr8’s OptiChem coatings used in microarraying slides. The 2-year license grants SCHOTT the non-exclusive right to manufacture and sell Nexterion Slide HS microarraying slides that use the protein-containing coating. In return, SCHOTT has paid Accelr8 a license fee and pre-paid royalties. This agreement follows an earlier license for a different type of OptiChem, signed in 2004.
Slide HS provides a surface coated with streptavidin, which is a type of protein. The coating provides a uniform and stable surface to maximize detection sensitivity for research in disease markers for diagnostics and in drug discovery.
According to David Howson, Accelr8’s president, “SCHOTT has developed industrial and academic customers for Slide HS. One of their industrial customers has launched a protein microarray product line that uses our coatings because of their performance advantages. We are very pleased to expand our relationship with SCHOTT Nexterion as the microarraying market continues to develop. In particular, we look forward to participating in the molecular diagnostics market as microarraying matures.”
About Accelr8
Accelr8 Technology Corporation (http://www.accelr8.com) is a developer of innovative materials and instrumentation for advanced applications in medical instrumentation, basic research, drug discovery, and bio-detection. Accelr8 is developing a rapid clinical pathogen platforms, the BACcel(TM)-1.0 and the BACcelr8r(TM), based on its innovative surface coatings, assay processing, and detection technologies. In addition, Accelr8 licenses certain of its proprietary technology for use in applications outside of Accelr8’s own products.
About SCHOTT
SCHOTT (http://www.schott.com) is an international technology-driven group that sees its core purpose as the lasting improvement of living and working conditions through special materials, components and high-tech solutions. Its main areas of focus are the household appliances industry, optics and electronics, pharmaceuticals and renewable energies. Schott has a presence in close proximity to its customers through highly efficient production and sales companies in all its major markets. It has 18,500 employees producing worldwide sales of 2 billion euros. The company’s technological and economic expertise is closely linked with its social and ecological responsibility.
The division SCHOTT Nexterion(R) Microarray Solutions (http://www.schott.com/nexterion) is specialized in high quality microarray products. As such, the company develops and markets a wide range of coated and uncoated glass substrates for DNA and protein microarraying under the brand Nexterion(R). SCHOTT Nexterion continuously expands its product portfolio and has several innovative products and services in the development pipeline.
Accelr8 Technology Corporation
CONTACT: John Metzger of Metzger Associates, +1-303-786-7000, ext. 2202,john@metzger.com, or David Howson of Accelr8 Technology, +1-303-863-8088,david.howson@accelr8.com.
